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Abstract
Background: Hypoxia induces the proliferation of lung fibroblasts in vivo and in vitro. However,
the subcellular interactions between hypoxia and expression of tumor suppressor p53 and cyclin-
dependent kinase inhibitors p21 and p27 remain unclear.
Methods: Normal human lung fibroblasts (NHLF) were cultured in a hypoxic chamber or exposed
to desferroxamine (DFX). DNA synthesis was measured using bromodeoxyuridine incorporation,
and expression of p53, p21 and p27 was measured using real-time RT-PCR and Western blot
analysis.
Results: DNA synthesis was increased by moderate hypoxia (2% oxygen) but was decreased by
severe hypoxia (0.1% oxygen) and DFX. Moderate hypoxia decreased p21 synthesis without
affecting p53 synthesis, whereas severe hypoxia and DFX increased synthesis of both p21 and p53.
p27 protein expression was decreased by severe hypoxia and DFX. Gene silencing of p21 and p27
promoted DNA synthesis at ambient oxygen concentrations. p21 and p53 gene silencing lessened
the decrease in DNA synthesis due to severe hypoxia or DFX exposure. p21 gene silencing
prevented increased DNA synthesis in moderate hypoxia. p27 protein expression was significantly
increased by p53 gene silencing, and was decreased by wild-type p53 gene transfection.
Conclusion: These results indicate that in NHLF, severe hypoxia leads to cell cycle arrest via the
p53-p21 pathway, but that moderate hypoxia enhances cell proliferation via the p21 pathway in a
p53-independent manner. In addition, our results suggest that p27 may be involved in compensating
for p53 in cultured NHLF proliferation.
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Background
Hypoxia is observed in many physiological and patholog-
ical conditions, including interstitial lung diseases, acute
respiratory distress syndrome, chronic obstructive pulmo-
nary diseases, asthma, wounded tissues, neoplasmas, and
atherosclerosis [1-5]. Under such hypoxic conditions,
fibroblast proliferation with enhanced production of
extracellular matrix (ECM) and marked fibrosis are key
components to understanding tissue remodeling [6,7].
Fibroblast proliferation with enhanced production of
ECM is an important feature of hypoxia-associated lung
diseases, and several in vitro studies have also shown that
exposure to moderate hypoxia stimulates the proliferation
of lung fibroblasts, with enhanced production of collagen
molecules [2,8,9]. In addition, hypoxia is one of the fac-
tors known to cause secondary pulmonary hypertension
and pulmonary vascular remodeling [2]. According to a
WHO statement in 1996, there were approximately 140
million people living at altitudes above 2500 m and there
are several areas of permanent habitation at altitudes in
excess of 4000 m. After several weeks of exposure to high
altitude, lowlanders develop pulmonary hypertension,
which is not completely reversed by supplemental oxygen
[10], suggesting development of vascular remodeling of
the lung [11]. Secondary pulmonary hypertension is char-
acterized by proliferation of vascular smooth muscle cells
and pulmonary arterial fibroblasts with enhanced deposi-
tion of ECM in small pulmonary vessels [12-14]. These
results suggest that hypoxic enhancement of lung fibrob-
last proliferation contributes to the deposition of collagen
fibrils in the lung and progression of hypoxia-associated
lung diseases.
Under normal physiological conditions, the majority of
pulmonary cells are in a quiescent state, so for prolifera-
tion of pulmonary cells, which underlies pulmonary
remodeling, cells must enter the cell cycle. The most
important molecular event necessary for progress of the
cell cycle is phosphorylation of the retinoblastoma pro-
tein by cyclin-dependent kinase (CDK)-cyclin complexes
[15]. CDK activity can be inhibited by CDK inhibitors
(CKI) such as p21 and p27. Up-regulation of CKI blocks
cell cycle progression in the G1 phase, and down-regula-
tion of CKI is required for entry into the S phase [7]. How-
ever, the effect of hypoxia on mammalian cell
proliferation seems to be dependent on the cell type and
on oxygen concentration. In several cell types, severe
hypoxia or chemically induced anoxia has been shown to
induce G1 cell cycle arrest [16,17], whereas moderate
hypoxia has been shown to enhance cell proliferation
[3,18,19]. The results of previous studies have suggested
that p21 plays an important role in oxygen-dependent cell
proliferation [20,21], and that p27 regulates both hypoxic
pulmonary remodeling and cell cycle arrest in severe
hypoxia [17,22-25].
CKI p21 is a key regulator of the cell cycle when cells are
exposed to oxidative stress or NO, and plays an important
role in pulmonary arterial smooth muscle cell (PASMC)
proliferation via induction of p53 [26,27]. In tumors
expressing wild-type p53, the locations of cells undergo-
ing apoptosis strongly correlate with regions of hypoxia,
whereas tumors expressing mutant p53 have lower levels
of apoptosis in hypoxic regions [28]. p53 knock-out
mutant cells are more resistant to hypoxia-induced apop-
tosis, and have a selective growth advantage compared
with wild-type p53 cells [28,29]. These results support the
view that p53 has opposite functions toward cell prolifer-
ation under hypoxia. In addition, p53 accumulation
under hypoxic conditions is linked to hypoxia inducible
factor-1α (HIF-1α), which is known to be a central tran-
scriptional factor operating during hypoxia toward angio-
genesis [30,31].
Given these previous findings, it seems likely that p21,
p27 and p53 are key mediators in the hypoxic prolifera-
tion of lung fibroblasts. However, little is known about
the interactions between these proteins in this situation.
Moreover, it is also uncertain whether hypoxic accumula-
tion of p53 induces functional p21 protein [14,32-34],
since severe hypoxia and anoxia have been reported to
induce p53 protein by a pathway different from the path-
way induced by DNA-damaging agents [35]. The purpose
of this study was to investigate the participation of and
interaction between p21, p27 and p53 with respect to the
effect of hypoxic pulmonary proliferation in cultured nor-
mal human lung fibroblasts (NHLF) during hypoxia, and
with respect to anoxia chemically induced by desferrox-
amine (DFX). DFX is known as an iron chelator which
depletes iron and inhibits oxygen, Fe2+-, and oxoglutarate-
dependent dioxygenases [36].
Methods
Chemicals
Chemicals and materials were obtained from the follow-
ing sources: FGM-2 medium, recombinant human fibrob-
last growth factor (FGF), gentamycin, streptomycin and
amphotericin B came from Sanko Junyaku Co., Ltd.
(Tokyo, Japan); the bromodeoxyuridine (BrdU) prolifera-
tion assay kit came from OncogeneTM (Cambridge, MA,
USA); the ECL system came from Amersham (Bucking-
hamshire, UK); Moloney murine leukemia virus reverse
transcriptase came from Toyobo Co. Ltd. (Osaka, Japan);
the QuantitechTM SYBR Green PCR kit came from Qiagen
(Santa Clarita, CA, USA); Lipofectamine 2000, 4–12%
Bis-Tris Nupage gels, and MES-SDS running buffer came
from Invitrogen (Carlsbad, CA, USA); the DC protein
assay kit and polyvinylidene difluoride (PVDF) mem-
branes came from Bio-Rad Laboratories (Richmond, CA,
USA); rabbit anti-p21 polyclonal antibody, rabbit anti-
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antibody, mouse anti-β-actin monoclonal antibody, and
horseradish peroxidase-conjugated goat anti-mouse and
rabbit came from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA, USA). All other chemicals were purchased from
Sigma (St. Louis, MO, USA).
Cell cultures
NHLF were supplied by Sankou Junyaku Co., Ltd. and
grown in FGM-2 medium containing 2% fetal bovine
serum (FBS) with 50 μg/ml gentamycin, 50 ng/ml ampho-
tericin B and 1 ng/ml recombinant human FGF. Cells were
cultured in 75-cm2 tissue culture flasks (Corning, NY,
USA) in a cell-culture incubator (37°C, 5% CO2, and 95%
air), and used after the seventh passage following trypsini-
zation. According to the manufacture's data sheet, NHLF
are obtained from human peripheral lung tissue with
enzymatic digestion, and the cells are confirmed negative
staining for smooth muscle α-actin, cytokeratin 18, cytok-
eratin 19, and von Willebrand factor. The light micro-
scopic appearance of NHLF was unchanged and we
confirmed negative staining of smooth muscle α-actin up
to seventh passage, which excluded the transformation of
NHLF into a myofibroblast phenotype. Oxygen concen-
trations (0.1 – 10%) were modified using N2-CO2 incuba-
tors (BNR-110M; Tabai ESPEC Corp., Tokyo, Japan; 10–
0233, Ikemoto Rika Kogyo, Co., Ltd., Tokyo, Japan).
Assay of BrdU incorporation by NHLF
NHLF were seeded in 96-well culture disks at a density of
6,000 cells/cm2 and incubated for 48 h in serum-free Dul-
becco's modified Eagle's medium (DMEM), after which
the medium was changed to DMEM with 10% FBS and
antibiotics. The cells were then incubated for another 24
h in various oxygen concentrations, and various concen-
trations of DFX were added to some cultures. BrdU incor-
poration was measured using a BrdU proliferation assay
kit in accordance with the manufacturer's protocol.
Briefly, the cells were labeled with 10 ng/ml BrdU during
incubation. After labeling, the cells were washed three
times with cold phosphate-buffered saline (PBS), fixed,
air dried and treated with mouse anti-BrdU monoclonal
antibody (1:1000). After aspiration of the antibody solu-
tion, the cells were washed three times and incubated with
peroxidase goat anti-mouse IgG (1:2000) at room temper-
ature for 30 min, then the cells were washed three times
and 100 μM substrate solution was added to each well.
Plates were incubated for 10 min in the dark, after which
dual-wavelength absorbance at 450 – 540 nm was meas-
ured.
Propidium iodide staining
To determine whether the cell cycle is influenced by oxy-
gen concentration, flow cytometric analysis with propid-
ium iodide staining was performed. NHLF were seeded
into 6-well culture disks at a density of 6,000 cells/cm2
and incubated for 48 h in serum-free DMEM, after which
the medium was changed to DMEM with 10% FBS and
antibiotics. Next, the cells were incubated for 24 h in var-
ious concentrations of oxygen. To measure the DNA con-
tent, the cells were harvested using trypsin and
ethylenediamine tetraacetic acid (EDTA) and fixed with
70% ethanol. The ethanol was removed and cells were
incubated in PBS containing RNase (172 kunits/ml) at
37°C for 30 min, stained with propidium iodide (50 μg/
ml), and suspended in PBS for 30 min on ice. DNA fluo-
rescence was measured and flow cytometric analyses were
performed using an EPICS XL flow cytometer (Beckman
Coulter, CA, USA).
Real-time RT-PCR analysis of p21, p27, and p53 mRNA
NHLF were cultured in 6-well flat-bottomed culture plates
at a density of 6,000 cells/cm2 and cultured for 48 h in
serum free DMEM. The cells were washed twice with PBS,
then placed in DMEM supplemented with 10% FBS and
antibiotics in various concentrations of oxygen for the
indicated times with or without 100 μM DFX. The cells
were then harvested by trypsinization, washed three
times, and pelleted by centrifugation. Total cellular RNA
was obtained from the cells by a single extraction with an
acid guanidinium thiocyanate-phenol-chloroform mix-
ture [26]. RT was performed using 0.5 μg of total RNA.
cDNA synthesis was performed using 200 U of Moloney
murine leukemia virus reverse transcriptase, 5 μM oli-
goDT, 1 mM dNTP solution, and 3 mM Mg2+ in a volume
of 20 μl. The temperature profile was comprised of
annealing at room temperature for 5 min, extension at
44°C for 40 min, and termination at 99°C for 5 min. PCR
was performed for the resulting RT products using oligo-
nucleotide primers specific for p21, p27, p53, and β-actin.
The primers used were as follows: p21 forward primer 5'-
GGAAGACCATGTGGACCTGT-3', reverse primer 5'-
GGCGTTTGGAGTGGTAGAAA-3'; p27 forward primer 5'-
GCCCTCCCCAGTCTCTCTTA-3', reverse primer 5'-
TCAAAACTCCCAAGCACCTC-3'; p53 forward primer 5'-
GTTCCGAGAGCTGAATGAGG-3', reverse primer 5'-
TTATGGCGGGAGGTAGACTG-3'; β-actin forward primer
5'-GCAAGCAGGAGTATGACGAG-3', reverse primer 5'-
CAAATAAAGCCATGCCAATC-3'. All PCR reactions were
performed with a LightCycler™ PCR system (Roche Diag-
nostics, Meylan, France) using DNA-binding SYBR Green
dye for detection of the PCR products. The cycling condi-
tions were as follows: initial denaturation at 95°C for 15
min, followed by 50 cycles of denaturation at 94°C for 15
s, annealing at 55°C for 15 s, and extension at 72°C for
15 s. The β-actin gene was used as a reference. The PCR
products were isolated from the LightCycler™ glass capil-
laries and visualized by electrophoresis on 1.5% agarose
gels followed by ethidium bromide staining to confirm
the products. Each assay was replicated in six independent
experiments.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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Analysis of p21 mRNA stability
NHLF (6,000 cells/cm2) were seeded into 6-cm dishes for
48 h in serum-free DMEM. The cells were washed twice
with PBS, then placed in DMEM containing 10% FBS and
cultured under various oxygen concentrations for the
indicated periods with or without 100 μM DFX in the
presence of the transcription inhibitor actinomycin D (Act
D) (400 nM). The cells were then counted and p21 mRNA
stability was examined per 50,000 cells incubated with Act
D using real-time RT-PCR. Each assay was replicated in six
independent experiments.
Western blot analysis
NHLF were seeded into 10-cm dishes at a density of 6,000
cells/cm2 and cultured for 48 h in serum-free DMEM. The
cells were washed twice with PBS, then placed in DMEM
supplemented with 10% FBS and antibiotics. Cells were
then cultured in various oxygen concentrations for the
indicated times with or without 100 μM DFX. After incu-
bation, the cells were harvested and resuspended in pro-
tein lysis buffer (150 mM NaCl, 20 mM Tris-HCl, 1%
NP40, 10 mM EDTA, 10% glycerol, 1 mM PMSF, 10 μg/
ml aprotinin, 1 μg/ml leupeptin, 1 μg/ml pepstatin), then
incubated for 30 min on ice. After incubation, the cell lysis
buffers were centrifuged at 10,000 g for 15 min at 4°C to
remove the cell fragments, and the supernatants were ana-
lyzed for protein content using a DC protein assay kit.
Each sample was quantified, and then 25 μg of protein
was loaded onto each lane of a 4 – 12% Bis-Tris Nupage
gel with MES SDS running buffer, according to the manu-
facturer's instructions. The gel was transferred to a PVDF
membrane by electrophoresis at 100 V for 1 h. The mem-
brane was blocked using PBS, 0.2% Tween 20 (PBS-T) and
5% nonfat milk at room temperature for 1 h. All antibod-
ies were diluted in the same blocking buffer. The mem-
brane was then probed with rabbit anti-p21 polyclonal
antibody (1:1000 dilution), rabbit anti-p27 polyclonal
antibody (1:1000 dilution), mouse anti-p53 monoclonal
antibody (1:2000 dilution), and mouse anti-β-actin mon-
oclonal antibody (1:5000 dilution), and then incubated
for 1 h at room temperature. After incubation, the mem-
brane was washed with PBS-T and incubated with horse-
radish peroxidase-conjugated goat anti-rabbit or mouse
IgG (1:2000 dilution) for 2 h at room temperature. After
washing with PBS-T, an ECL system was used to detect the
proteins. Each assay was replicated in four independent
experiments.
Transfection of small interfering RNA (siRNA) into NHLF
p21, p27, p53 and control siRNAs were designed and syn-
thesized by B-Bridge International Inc. (Sunnyvale, CA,
USA). The p21, p27, p53 and negative control siRNA tar-
get sequences were 5'-CGUCAGAACCCAUGCGGCA-3',
5'-GGAGCAAUGCGCAGGAAUA-3', 5'-CUGGAAGA CU
CCAGUGGUA-3', and 5'-AUCCGCGCGAUAGUACGUA-
3', respectively. NHLF were seeded into 6-cm dishes and
incubated in DMEM with 10% FBS for 24 h, after which
time they had reached about 60% confluence. After rins-
ing, the cells were incubated with liposome solution com-
prised of Opti-MEM medium, Lipofectamine 2000 (10 μl/
ml), and siRNA (0 – 100 or 50 nM) with 10% FBS. After 8
h of incubation, the same amount of Opti-MEM medium
containing 10% FBS was added to the dishes or plates and
the incubation was continued for 16 h. After 24 h of trans-
fection, the liposome solutions were replaced with DMEM
containing 10% FBS. Next, the cells were harvested and
seeded into 6-cm dishes or 96-well plates at a density of
6,000 cells/cm2, then cultured for 24 h in various concen-
trations of oxygen or with 100 μM DFX. After incubation,
BrdU incorporation by the transfected cells was measured,
and Western blot analysis was performed to confirm tar-
get gene silencing by each siRNA.
Transient transfection of the p53 gene into NHLF
pCMV p53 (wild-type p53 genes), pCMV p53mt135
(dominant-negative mutants of p53) and pCMV β-galac-
tosidase were purchased from Clontech (San Jose, CA,
USA). All plasmids were purified using Qiagen plasmid
midi and maxi kits. NHLF were seeded into 6-cm dishes
and incubated in DMEM containing 10% FBS for 24 h,
after which time they had reached about 70% confluence.
After rinsing, the cells were incubated with 2.5 ml of lipo-
some solution comprised of serum-free Opti-MEM
medium, Lipofectamine 2000 (10 μl/plate), Lipo-
fectamine-Plus reagent (40 μl/plate), and plasmid DNA (3
μg/plate). After 5 h of incubation, the same amount of
Opti-MEM medium containing 20% FBS was added to the
dishes and the incubation was continued for another 19
h. After 24 h of transfection, the cells were washed twice
with PBS, and the liposome solution was replaced with
DMEM containing 10% FBS. After 24 h incubation, pro-
tein expression of p21, p27 and p53 was examined by
Western blot analysis. We assessed transfection efficacy by
co-transfecting cells with pCMV β-galactosidase and deter-
mining the number of cells that stained blue with X-gal.
Briefly, cells on collagen-coated membranes were fixed
with 0.25% glutaraldehyde for 10 min, washed twice with
PBS containing 1 mM MgCl2, and stained with 1 mg/ml X-
gal in a solution of 1 mM MgCl2, 5 mM K3Fe(CN)6, and 5
mM K4Fe(CN)6 for 4 h. The transfection efficacy was rou-
tinely found to be more than 40%.
Statistical analysis
Results are expressed as mean ± SE. Statistical analysis was
performed using ANOVA with Bonferroni corrections for
multiple comparisons. Comparisons were considered sta-
tistically significant at p < 0.05.
Results
Effect of hypoxia and DFX on NHLF proliferation
Moderate hypoxia (2% oxygen) promoted the incorpora-
tion of BrdU in serum-stimulated NHLF, whereas severeRespiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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hypoxia (0.1% oxygen) and 100 μM DFX suppressed
BrdU incorporation (Fig. 1A). Cell cycle analysis using
propidium iodide staining revealed that severe hypoxia
and 100 μM DFX significantly decreased the percentage of
cells in S plus G2/M phases, whereas moderate hypoxia
had the opposite effect (Fig. 1B).
Effect of hypoxia and DFX on expression of p21 and p53
Real-time RT-PCR showed that expression of p21 mRNA
in NHLF decreased when cells were exposed to moderate
hypoxia, whereas severe hypoxia and DFX both signifi-
cantly increased the expression of p21 mRNA. In contrast,
no significant changes in the expression of p27 and p53
mRNA were detected (Fig. 2).
Western blot analysis showed that p21 protein expression
was decreased by moderate hypoxia, compatible with the
results of mRNA expression analysis. Severe hypoxia and
DFX both increased expression of p21 and p53 protein,
and decreased expression of p27 protein (Fig. 3).
To confirm the effect of hypoxia on p21 mRNA expres-
sion, we assessed p21 mRNA stability during hypoxia
using Act D. p21 mRNA stability was significantly
Effect of hypoxia and DFX on NHLF proliferation Figure 1
Effect of hypoxia and DFX on NHLF proliferation. A; Effects of hypoxia and DFX on BrdU incorporation in cultured 
NHLF: Cultured NHLF were exposed to 0.1% or 2% oxygen, or 100 μM DFX, in the presence of BrdU for 24 h. Severe 
hypoxia (0.1% oxygen) and DFX suppressed BrdU incorporation, but moderate hypoxia (2% oxygen) significantly enhanced 
incorporation. Data are expressed as mean ± SE (n = 6). *P < 0.05 versus the 21% oxygen control. B; Cell cycle analysis of 
NHLF exposed to hypoxia and DFX: Cultured NHLF (synchronized at G0/1 phases by serum depletion) were exposed to 0.1% 
or 2% oxygen, or 100 μM DFX, in the presence of 10% FBS. After 24 h, the cells were harvested and cell cycle analyses were 
performed using a flow cytometer with propidium iodide staining. Severe hypoxia and DFX significantly decreased the percent-
age of cells in the S plus G2/M phases, whereas moderate hypoxia had the opposite effect. Representative histograms are 
shown and the bar graph shows data expressed as mean ± SE (n = 4). Open bars, percentages of cells in the G0/1 phases; solid 
bars, percentages of cells in the S + G2/M phases. *P < 0.05 versus the 21% oxygen control.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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decreased under moderately hypoxic conditions relative
to the 21% oxygen control (Fig. 4).
Effect of p53 gene induction and silencing in NHLF
Transfection of cells with wild-type (Wt) and dominant-
negative mutation (DN) forms of p53 induced expression
of a massive amount of p53 protein. Only transfection
with Wt p53 induced expression of p21 protein and
decreased expression of p27 protein (Fig. 5A). RT-PCR
analysis showed that transfection with Wt p53 induced
p53 and p21 mRNA expression without affecting p27
mRNA expression (Fig. 5B). In contrast, transfection with
p53 siRNA inhibited expression of p53 and p21 protein,
and dose-dependently induced expression of p27 protein
(Fig. 6A). p53 gene silencing significantly suppressed p53
and p21 mRNA expression without affecting p27 mRNA
expression (Fig. 6B).
Effect of hypoxia and DFX on proliferation in siRNA-
transfected NHLF
Transfection of NHLF with p21, p27, and p53 siRNA sig-
nificantly inhibited the expression of each target protein.
p53 protein expression was significantly induced by DFX
and severe hypoxia. p27 protein expression was signifi-
cantly increased by p53 gene silencing, and decreased by
DFX and severe hypoxia. p21 protein expression was sig-
nificantly inhibited by p53 gene silencing, inhibited by
moderate hypoxia, and induced by DFX and severe
hypoxia (Fig. 7A, B). BrdU incorporation by p21 and p27
siRNA-transfected cells was significantly increased com-
pared with the control siRNA-transfected cells in 21% oxy-
gen. In moderate hypoxia, BrdU incorporation by p27
and p53 siRNA-transfected cells was significantly
increased compared with control siRNA-transfected cells,
whereas p21 siRNA-transfected cells did not undergo sig-
nificantly more proliferation than control siRNA-trans-
fected cells. In contrast, in severely hypoxic cells and cells
Expression of p21 and p53 mRNA in NHLF exposed tohy- poxia or DFX Figure 2
Expression of p21 and p53 mRNA in NHLF exposed 
tohypoxia or DFX. Cultured NHLF were exposed to 0.1% 
or 2% oxygen, or 100 μM DFX, for 24 h, then real-time RT-
PCR analyses were performed. The amount of p21 mRNA 
was increased by severe hypoxia but decreased by moderate 
hypoxia. No significant changes were detected in the expres-
sion of p27 and p53 mRNA. The bar graph shows the ratios 
of p21 (open bars), p27 (solid bars), and p53 (shaded bars) 
mRNA relative to the amount of β-actin mRNA. Data are 
expressed as mean ± SE (n = 6). *P < 0.05 versus the 21% 
oxygen control.
Expression of p21, p27 and p53 protein in NHLF exposed to  hypoxia or DFX Figure 3
Expression of p21, p27 and p53 protein in NHLF 
exposed to hypoxia or DFX. Cultured NHLF were 
exposed to 0.1% or 2% oxygen, or 100 μM DFX, for 24 h, 
then Western blot analyses were performed. Expression of 
p21 was decreased by moderate hypoxia and increased by 
severe hypoxia and DFX. Expression of p53 was increased by 
severe hypoxia and DFX. Expression of p27 was decreased 
by severe hypoxia and DFX. The photomicrograph shown is 
a representative image from four similar experiments, and 
the bar graph shows the density ratios of p21 (open bars), 
p27 (solid bars), and p53 (shaded bars) protein bands relative 
to β-actin bands. Data are expressed as mean ± SE (n = 4). *P 
< 0.05 versus the 21% oxygen control.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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exposed to DFX, BrdU incorporation was significantly
increased by p21 and p53 siRNA transfection relative to
control siRNA-transfected cells (Fig. 7C).
Discussion
In the present study, we observed that moderate hypoxia
(2% oxygen) enhanced the proliferation of NHLF,
whereas severe hypoxia and DFX induced cell cycle arrest.
We also demonstrated that both severe hypoxia and DFX
cause cell cycle arrest via the p53-p21 pathway, but that
moderate hypoxia enhances cell proliferation via a p21
pathway that is independent of p53 and p27. Further, our
results suggest that p27 may be involved in compensating
for p53 in serum-stimulated NHLF proliferation.
Increased levels of growth factors derived from the accu-
mulation of HIF-1α are thought to regulate pulmonary
arterial cell proliferation under hypoxic conditions, given
that partial HIF-1α deficiency decreases the remodeling of
pulmonary arterioles in animals exposed to chronic
hypoxia [37]. Although HIF-1α regulates various tran-
scriptional genes encoding angiogenic factors, severe
hypoxia and iron depletion induce cell growth arrest. Our
finding that severe hypoxia (0.1% oxygen) suppresses
nucleotide synthesis is in line with the findings of previ-
ous studies in which several tumor cell lines were cultured
under hypoxic conditions or with iron chelators [16,17].
In other studies, it has been found that moderate hypoxia
(1 – 5% oxygen) enhances the proliferation of rat and
bovine PASMC, airway-smooth muscle cells, lung fibrob-
lasts and mesangial cells [3,18,19,38]. Our findings that
DNA synthesis is increased during moderate hypoxia, and
that the NHLF cell cycle progresses more quickly under
hypoxic than normoxic conditions, are also compatible
with previous findings.
There are some discrepancies regarding serum stimulation
when we compare our results using NHLF and previous
data obtained with human pulmonary artery fibroblasts
which proliferate in the face of hypoxia and low levels of
serum stimulation [39-41]. We do not have a complete
answer for this discrepancy at this time. However, several
papers have shown that normal fibroblasts (non-pulmo-
nary artery fibroblasts) exposed to hypoxia need relatively
high serum concentrations for posttranscriptional
processing or cell proliferation [7,42], suggesting that pul-
monary artery fibroblasts have a greater proliferative
potential than normal fibroblasts. In addition, we assume
that several CDK inhibitors associated with replicative
senescence, which has been known to be associated with
an increase in expression of p16, p21, and p19 [43,44],
may play a role in this discrepancy. Further, serum deple-
tion causes cell cycle arrest and an accumulation of p27
protein, and this degradation is enhanced by serum stim-
ulation and hypoxia [45]. Taken together, we speculate
that this increase of CDK inhibitors likely influences cell
growth and reactions to serum stimulation during
hypoxia, and our cells require relatively high levels of
serum to grow compared to the pulmonary artery fibrob-
lasts. However, further studies will be necessary to con-
firm this hypothesis.
p21 has been shown to regulate cell cycle progression
through either a p53-dependent or -independent pathway
[26,27,46,47]. Under conditions of moderate hypoxia, we
observed decreased p21 expression and increased DNA
synthesis with progress of the cell cycle in NHLF. In these
cells, however, p53 protein was not affected, and
decreased p21 stability was observed. These results indi-
cate that the decrease in p21 expression in moderate
hypoxia is independent of the p53 pathway, and is prob-
ably induced by a decrease in the stability of p21 mRNA.
The precise molecular mechanism responsible for p53-
independent p21 mRNA instability after exposure to
moderate hypoxia remains unclear. However, Esposio et
al. found that p21 protects cells from oxidative stress by
inhibiting DNA replication, and that oxidative stress sta-
bilizes p21 mRNA through mitogen-activated protein
kinase (MAPK) [48,49]. In addition, hyperoxic conditions
and application of hyperbaric oxygen induce p21 protein
independently of p53 protein and lung injury caused by
oxidative stress [27]. These observations may explain why
Stability of p21 mRNA exposed to hypoxia in NHLF Figure 4
Stability of p21 mRNA exposed to hypoxia in NHLF. 
Cultured NHLF were exposed to 0.1% or 2% oxygen, or 100 
μM DFX, and the stability of p21 mRNA was measured using 
RT-PCR after addition of 400 nM Act D. The stability of p21 
mRNA significantly decreased after 8 and 24 h of moderate 
hypoxia relative to the 21% oxygen control. Data are per-
centages of each maximal mRNA expression. 21% oxygen 
control (open bars), 2% oxygen (solid bars), 0.1% oxygen 
(shaded bars), and DFX (diagonal bars). Data are expressed 
as mean ± SE (n = 6). *P < 0.05 versus the 21% oxygen con-
trol.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
Page 8 of 12
(page number not for citation purposes)
a p53-independent decrease in p21 was observed in mod-
erately hypoxic conditions. The decrease in p21 and cell
proliferation during moderate hypoxia could be due to
the secondary effects of decreased oxidative stress and
release of free oxygen radicals. However, further studies
are essential in order to determine the nature of the
hypoxic regulation of p21.
p53 protein expression must ordinarily rely on post-tran-
scriptional events, given that p53 protein is a very short-
lived protein owing to fast proteasomal degradation, and
that stabilization of the protein in response to a variety of
stresses, including hypoxic stress, has been found to evoke
a rapid increase in p53 levels [50]. In the present study we
found that p53 protein expression was increased after
severe hypoxic exposure and incubation with DFX, and
that p21 mRNA and protein expression also occurred.
However, in several previous studies using tumor cell
lines with the wild-type p53 gene, p53 accumulation
caused by iron chelators was found to induce p21 mRNA,
but p21 protein was not expressed in response to inhibi-
tion of p21 translation [16,17,32]. Fukuchi et al. reported
that p21 protein accumulation caused by iron chelators
was dependent on inhibition of the proteasome [16], and
Le et al. reported that p21 translation in the presence of
DFX required iron, since this translational disorder could
be reversed by the iron donor ferric ammonium citrate
[34]. This discrepancy between our results and those of
Effect of p53 gene induction on p21, p27 and p53 expression in NHLF Figure 5
Effect of p53 gene induction on p21, p27 and p53 expression in NHLF. Expression of p21, p27 and p53 was examined 
in NHLF transfected with plasmids encoding wild-type (Wt) and dominant-negative mutation (DN) forms of the p53 gene, or 
an empty vector (Mock). A: Western blot analysis showed that Wt p53 transfection induced p21 protein expression and 
decreased p27 protein expression, whereas no significant changes in p21 and p27 protein expression were observed for the 
Mock- and DN-transfected cells. The photomicrograph shown is a representative image from four similar experiments, and the 
bar graphs show the density ratios of p21 (open bars), p27 (solid bars), and p53 (shaded bars) protein bands relative to β-actin 
bands. Data are expressed as mean ± SE (n = 4). *P < 0.05 versus Mock control. B: RT-PCR analysis showed that Wt p53 
transfection induced p21 and p53 mRNA expression, whereas p27 mRNA was not affected. The bar graph shows the ratios of 
p21, p27 and p53 mRNA relative to the amount of β-actin mRNA. Open bars, Mock-transfected cells; solid bars, Wt p53-
transfected cells. Data are expressed as mean ± SE (n = 6). *P < 0.05 versus Mock transfection.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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previous studies could be explained by differences in the
cell lines used, because different cell lines may have differ-
ent hypoxic tolerances relative to each proteasomal activ-
ity or capacity for iron content. However, the precise
mechanism underlying this discrepancy is unknown and
the matter requires further investigation.
Mutations in p53 and reduced expression of p27 are fre-
quently observed in many human cancer cells, and
reduced expression of p27 is a common feature in cancers
with mutations in p53 [51-53]. Tumor development in
p53 mutant mice was also found to be accelerated by loss
of only a single allele of p27 [52]. These findings indicate
that p27 is an important cell cycle regulator in cells that
have a mutated p53 gene. In the present study, gene
silencing of p53 increased p27 protein expression, and
gene silencing of p27 could not suppress the increase in
moderate hypoxia-induced DNA synthesis. p27 protein
expression was not affected by mild hypoxia in our exper-
iments. On the contrary, p21 protein expression in p27
gene silenced NHLF was significantly decreased in mild
hypoxia. These results indicate that p27 gene silencing
could not suppress the growth of hypoxic NHLF because
the regulation of the p21 protein, which may have a criti-
cal role in mild hypoxic proliferation, was still active. Sur-
prisingly, silencing of the p53 gene did not induce a
significant increase in DNA synthesis at ambient oxygen
concentrations, whereas p21 expression was significantly
suppressed in these cells and silencing of the p21 gene had
a marked effect on proliferation. Given these results, we
Effect of p53 gene silencing on expression of p21, p27 and p53 in NHLF Figure 6
Effect of p53 gene silencing on expression of p21, p27 and p53 in NHLF. Expression of p21, p27 and p53 was exam-
ined in NHLF transfected with p53 siRNA (p53 KD) or control siRNA (Control). A: Western blot analysis showed that p53 
KD dose-dependently decreased the amount of p53 and p21 protein and increased the amount of p27 protein. The photomi-
crograph shown is a representative image from four similar experiments, and the bar graphs show the density ratios of p21 
(open bars), p27 (solid bars), and p53 (shaded bars) protein bands relative to β-actin bands. Data are expressed as mean ± SE 
(n = 4). *P < 0.05 versus control (no siRNA). B: RT-PCR analysis showed that p53 KD decreased the expression of p21 and 
p53 mRNA, whereas p27 mRNA was not affected relative to the control. Open bars, control siRNA-transfected cells; solid 
bars, p53 siRNA-transfected cells. Data are expressed as mean ± SE (n = 6). *P < 0.05 versus control siRNA transfection.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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Effect of hypoxia and DFX on proliferation in p21, p27 and p53 gene silenced NHLF Figure 7
Effect of hypoxia and DFX on proliferation in p21, p27 and p53 gene silenced NHLF. NHLF transfected with con-
trol (Control), p21 (p21 KD), p27 (p27 KD), or p53 (p53 KD) siRNA were exposed to 0.1% or 2% oxygen, or 100 μM DFX. 
Western blotting was performed, and BrdU incorporation was measured. Transfection with p21, p27, and p53 siRNA signifi-
cantly inhibited the expression of each target protein. p27 protein expression was increased by p53 KD transfection, and 
decreased by DFX and severe hypoxia. p21 protein expression was decreased by p53 KD transfection, decreased by moderate 
hypoxia, and increased by DFX and severe hypoxia. A: The photomicrographs shown are representative images from four sim-
ilar experiments. B: The bar graphs show the density ratios of Control (open bars), p21 KD (solid bars), p27 KD (shaded bars), 
and p53 KD (diagonal bars) protein bands relative to β-actin bands. Data are expressed as mean ± SE (n = 4). *P < 0.05 versus 
control siRNA (Control). †P < 0.05 versus each siRNA in 21% oxygen. C: BrdU incorporation by p21 KD- and p27 KD-trans-
fected cells was significantly increased compared with control cells in 21% oxygen. For moderate hypoxia, BrdU incorporation 
by p27 KD- and p53 KD-transfected cells was significantly increased compared with control cells, but p21 KD-transfected cells 
did not undergo any significant increase in proliferation. In severely hypoxic cells and cells exposed to DFX, BrdU incorpora-
tion was significantly increased in p21 KD- and p53 KD-transfected cells compared with control cells. The bar graph shows 
data expressed as mean ± SE (n = 6). Control siRNA (open bars), p21 KD (solid bars), p27 KD (shaded bars), and p53 KD 
(diagonal bars). *P < 0.05 versus control siRNA (Control). †P < 0.05 versus each siRNA in 21% oxygen.Respiratory Research 2009, 10:17 http://respiratory-research.com/content/10/1/17
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conclude that p27 does not play a central role in oxygen-
dependent NHLF proliferation, but does play a role in
compensating for p53-suppressed proliferation in NHLF.
Wu et al. reported that in serum-stimulated fibroblasts
from p53 knock-out mice, p21 could not be activated, but
p27 protein could be induced without a decrease in cyclin
A expression [54]. This compensative role of p27 in the
loss of the p53 protein is in line with the results of our
study. In addition, our results regarding p21 and p53 gene
silencing also suggest that accumulation of p53 during
hypoxia or DFX treatment plays a critical role in cell cycle
regulation via the p53-p21 pathway.
Conclusion
We showed that decreased oxygen levels increased NHLF
proliferation but very low oxygen levels caused cell cycle
arrest. Decreased expression of p21 protein may play a
p53-independent role during hypoxia-induced NHLF pro-
liferation, but hypoxic cell cycle arrest is regulated by p21
induction by hypoxic accumulation of p53. p27 may have
a compensatory role for the p53 pathway. Hypoxic pul-
monary fibroblast proliferation may contribute to the
progression of hypoxia-associated fibroblastic lung dis-
eases and hypoxic pulmonary remodeling. We believe
that a better understanding of the cellular mechanisms in
hypoxic NHLF will lead to improved modes of therapy for
hypoxia-associated changes in lung tissue structure and
aid in the remodeling of the lung.
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